Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1981 2019

Clinical Trials
Radiation Oncology
Translational Medical Research
Health Services Research
Genomics
Neoplasms
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
regorafenib
Pharmacokinetics
Safety
Clinical Trials
Neoplasms
trans-crotonin
Therapeutics
Pharmaceutical Preparations

Research Output 1990 2017

  • 5532 Citations
  • 33 h-Index
  • 67 Article
  • 7 Review article
  • 2 Editorial

Nanoparticle-delivered chemotherapy: Old drugs in new packages

Lee, M. S., Claire Dees, E. & Wang, A. Z. Mar 15 2017 In : ONCOLOGY (United States). 31, 3

Research output: Research - peer-reviewReview article

Nanoparticles
Drug Therapy
Pharmaceutical Preparations
Drug Compounding
Clinical Trials
6 Citations

A multidisciplinary breast cancer brain metastases clinic: The university of North Carolina experience

McKee, M. J., Keith, K., Deal, A. M., Garrett, A. L., Wheless, A. A., Green, R. L., Benbow, J. M., Dees, E. C., Carey, L. A., Ewend, M. G., Anders, C. K. & Zagar, T. M. Jan 1 2016 In : Oncologist. 21, 1, p. 16-20 5 p.

Research output: Research - peer-reviewArticle

Brain Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Confidence Intervals
Brain
14 Citations

First-in-human phase i study of GSK2126458, an oral pan-class i phosphatidylinositol-3-kinase inhibitor, in patients with advanced solid tumor malignancies

Munster, P., Aggarwal, R., Hong, D., Schellens, J. H. M., Van Der Noll, R., Specht, J., Witteveen, P. O., Werner, T. L., Dees, E. C., Bergsland, E., Agarwal, N., Kleha, J. F., Durante, M., Adams, L., Smith, D. A., Lampkin, T. A., Morris, S. R. & Kurzrock, R. Apr 15 2016 In : Clinical Cancer Research. 22, 8, p. 1932-1939 8 p.

Research output: Research - peer-reviewArticle

Phosphatidylinositol 3-Kinase
Neoplasms
2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide
Maximum Tolerated Dose
Exanthema
156 Citations

Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib keynote-012 study

Nanda, R., Chow, L. Q. M., Dees, E. C., Berger, R., Gupta, S., Geva, R., Pusztai, L., Pathiraja, K., Aktan, G., Cheng, J. D., Karantza, V. & Buisseret, L. Jul 20 2016 In : Journal of Clinical Oncology. 34, 21, p. 2460-2467 8 p.

Research output: Research - peer-reviewArticle

Triple Negative Breast Neoplasms
pembrolizumab
Neoplasms
Safety
Head and Neck Neoplasms
1 Citations

Phase i Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience from Cancer Therapy Evaluation Program of the National Cancer Institute

Zeidner, J. F., Karp, J. E., Blackford, A. L., Foster, M. C., Dees, E. C., Smith, G., Ivy, S. P. & Harris, P. Mar 1 2016 In : Journal of the National Cancer Institute. 108, 3, djv335

Research output: Research - peer-reviewArticle

National Cancer Institute (U.S.)
Program Evaluation
Acute Myeloid Leukemia
Clinical Trials
Neoplasms